KENNETH SMITH: Open Payments
NPI 1396851689 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 16 payments from 10 companies in 2025. Trend: 2023 $176 · 2024 $108 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Lilly USA, LLC | 3 | $54 |
| PFIZER INC. | 2 | $43 |
| Electromed, Inc. | 2 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Novo Nordisk Inc | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
Products named: Korlym, REXULTI, MOUNJARO, PREVNAR 20, SMARTVEST, CAPLYTA, LEQVIO, SHINGRIX.
Industry payments across KS — which companies pay providers there.
